Cargando…
Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990982/ http://dx.doi.org/10.1186/2051-1426-1-S1-P76 |
_version_ | 1782312358934216704 |
---|---|
author | He, Li-Zhen Thomas, Lawrence J Testa, James Weidlick, Jeffrey Sisson, Crystal Hammond, Russell Vitale, Laura Marsh, Henry Keler, Tibor |
author_facet | He, Li-Zhen Thomas, Lawrence J Testa, James Weidlick, Jeffrey Sisson, Crystal Hammond, Russell Vitale, Laura Marsh, Henry Keler, Tibor |
author_sort | He, Li-Zhen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3990982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39909822014-05-01 Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models He, Li-Zhen Thomas, Lawrence J Testa, James Weidlick, Jeffrey Sisson, Crystal Hammond, Russell Vitale, Laura Marsh, Henry Keler, Tibor J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990982/ http://dx.doi.org/10.1186/2051-1426-1-S1-P76 Text en Copyright © 2013 He et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation He, Li-Zhen Thomas, Lawrence J Testa, James Weidlick, Jeffrey Sisson, Crystal Hammond, Russell Vitale, Laura Marsh, Henry Keler, Tibor Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models |
title | Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models |
title_full | Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models |
title_fullStr | Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models |
title_full_unstemmed | Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models |
title_short | Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models |
title_sort | combination therapies augment the anti-tumor activity of agonist cd27 mab in human cd27 transgenic mouse models |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990982/ http://dx.doi.org/10.1186/2051-1426-1-S1-P76 |
work_keys_str_mv | AT helizhen combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels AT thomaslawrencej combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels AT testajames combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels AT weidlickjeffrey combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels AT sissoncrystal combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels AT hammondrussell combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels AT vitalelaura combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels AT marshhenry combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels AT kelertibor combinationtherapiesaugmenttheantitumoractivityofagonistcd27mabinhumancd27transgenicmousemodels |